Thousand Oaks pharma giant Amgen Inc. is making a series of C-suite changes, triggered by the retirement announcement of Chief Technology Officer David Reese.
Reese, 63, is retiring effective June 1. He has served as the company’s first chief technology officer since 2023.
Sean Bruich, the current senior vice president of artificial intellig...